CeriBell, Inc., launched from a Stanford Bio-X Seed Grant, CeriBell rang the bell at Nasdaq and debuted as a public trading company!
In 2012, Stanford Bio-X affiliated faculty members Josef Parvizi and Chris Chafe received a Stanford Bio-X Seed Grant to create a stethoscope device for the brain. This Seed Grant launched CeriBell, Inc. – which made its market debut on Friday, October 11 in an IPO that is expected to generate $180.3 million in proceeds!